Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 02/11/2025 12:35:43 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 9657
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70966
Merry Christmas, folks!
(5)
Commando911
12/24/2021 10:56:00 PM
70965
Maybe Leo will apply for a NIIMBL grant from the
Commando911
12/23/2021 10:04:23 AM
70961
Response to a post on another board. Post:
(3)
Kelt
12/21/2021 6:03:41 PM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
70903
I agree Glad to finally hear from you.
(2)
Kelt
11/22/2021 7:56:04 PM
70899
Besides trying to hide the real issues with this
(6)
falcon74
11/18/2021 12:53:47 PM
70898
copy of my PM .. just now .. to another IPIX
(13)
4kids
11/18/2021 11:19:21 AM
70897
As noted previously, trial analysis is "ongoing"
(3)
bandg
11/18/2021 11:03:44 AM
70896
Update out
stocker11
11/18/2021 8:38:53 AM
70895
Innovation Pharmaceuticals Provides Brilacidin
(4)
bettingbig
11/18/2021 8:38:01 AM
70892
"...Florida teacher hospitalized with COVID-19
(2)
farrell
11/16/2021 2:07:28 PM
70891
No way to know that all analysis has been
(5)
bandg
11/16/2021 11:04:31 AM
70890
The CRO is doing/has completed all the data
(3)
petemantx
11/16/2021 10:53:53 AM
70889
Heparin interacts with the main protease of
Boneysteak
11/16/2021 6:23:50 AM
70888
While most of us view them as the elephant in the
(8)
DrTim
11/15/2021 7:45:18 PM
Newer
Older
Recent Articles
Unlock Your Financial Potential with XRP Mining Opportunities
Westport Fuel Systems Annual Meeting Highlights and Innovations
Teva Pharmaceuticals Gains Moody's Upgrade Amid Growth Strategy
XChange TEC.INC Faces Nasdaq Delisting but Plans to Appeal
GoldMining's Annual Meeting Yields Positive Voting Results
Delta Dental's Recognition as a Leading Workplace for Women
Ontario's Commitment to Infrastructure Enhances Workforce Growth
VolitionRx Shares Q1 2025 Financial Gains and Progress Update
Investigation into Foot Locker Acquisition: What Investors Should Know
Innovative Energy Plans by PG&E to Support California's Future
Discover Your Path to Tinnitus Relief with MyTinnitusNumber.org
PSE&G Enhances Support for Customers Amid Rising Energy Costs
Revolutionizing Humanitarian Aid with AI: MindHYVE.ai™ Collaboration
Transformative Treatments for Eosinophilic Esophagitis Unveiled
UNFI Drivers Achieve Significant Union Milestone with Teamsters
BioSyent's Impressive Financial Growth Captured in Q1 Results
J & J Snack Foods Corp. Declares New Cash Dividend for Shareholders
SUNation Energy Reveals Q1 Results and 2025 Financial Goals
Banzai International Shows Impressive Growth in Q1 2025
Binah Capital Group Posts Impressive Growth in Q1 2025
BioSyent Announces Exciting Dividend News for Investors
Unraveling Investment Risks in XP Inc. Securities Case
Horizon Copper Unveils Impressive Drill Findings from Hugo
Outstanding First Quarter Results for Moatable, Inc. Revealed
Vistra Expands Natural Gas Portfolio With Recent Acquisition
Investors Can Join Legal Action Against NAPCO Security
Growth Prospects for Cushing's Disease Treatment Methods
Upcoming Class Action Insights for Zynex Investors to Learn
Milbank Expands Appellate Team with Expert Colleen Roh Sinzdak
Gen Digital Embraces New Leadership as Peter Feld Steps Down
MOWI Introduces MOWI Signature: Premium Salmon for Food Service
AT&T Reveals Key Outcomes from Its Annual Stockholder Meeting
Investors in Cerevel Therapeutics Can Take Action Following Fraud Claims
Zenas BioPharma Investors Urged to Participate in Class Action
Key Outcomes of Precision Drilling’s Latest Shareholder Meeting
South Bow Corp Announces Impressive First Quarter Results
Rubis Welcomes New Leadership with Marc-Olivier Laurent
Mawson Infrastructure Group Sees Revenue Growth in Q1 2025
CAPREIT Launches New Equity Program for Future Growth
ERES Announces Upcoming Monthly Cash Distribution for 2025
Kneat Secures Agreement with Diagnostics Company for Growth
Troilus Gold Secures $35 Million for Project Advancement
XBP Europe Holdings Posts Noteworthy Q1 Performance Data
South Bow Corp. Reports Positive Outcomes from Shareholder Meeting
Biofrontera Inc. Delivers Strong Q1 2025 Performance Update
Norway Joins the Artemis Accords to Enhance Space Cooperation
Justice Necessary Tackles Period Poverty with Huge Initiative
Aris Mining Reports Annual Meeting Voting Results and Updates
U Power Limited Shares Impressive Annual Report Gains for 2024
Legal Action Initiated Against Montage Laguna Beach for Wage Issues